These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 12416809

  • 1. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle.
    Erskine RJ, Bartlett PC, VanLente JL, Phipps CR.
    J Dairy Sci; 2002 Oct; 85(10):2571-5. PubMed ID: 12416809
    [Abstract] [Full Text] [Related]

  • 2. Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis.
    Schukken YH, Bennett GJ, Zurakowski MJ, Sharkey HL, Rauch BJ, Thomas MJ, Ceglowski B, Saltman RL, Belomestnykh N, Zadoks RN.
    J Dairy Sci; 2011 Dec; 94(12):6203-15. PubMed ID: 22118109
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows.
    Oliver SP, Gillespie BE, Headrick SJ, Moorehead H, Lunn P, Dowlen HH, Johnson DL, Lamar KC, Chester ST, Moseley WM.
    J Dairy Sci; 2004 Aug; 87(8):2393-400. PubMed ID: 15328260
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli.
    Shpigel NY, Levin D, Winkler M, Saran A, Ziv G, Böttner A.
    J Dairy Sci; 1997 Feb; 80(2):318-23. PubMed ID: 9058274
    [Abstract] [Full Text] [Related]

  • 5. Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis.
    Fuenzalida MJ, Ruegg PL.
    J Dairy Sci; 2019 Jun; 102(6):5438-5457. PubMed ID: 30981475
    [Abstract] [Full Text] [Related]

  • 6. Short communication: Efficacy of parenteral ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle.
    Wenz JR, Garry FB, Lombard JE, Elia R, Prentice D, Dinsmore RP.
    J Dairy Sci; 2005 Oct; 88(10):3496-9. PubMed ID: 16162523
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of extended pirlimycin therapy for treatment of experimentally induced Streptococcus uberis intramammary infections in lactating dairy cattle.
    Oliver SP, Almeida RA, Gillespie BE, Ivey SJ, Moorehead H, Lunn P, Dowlen HH, Johnson DL, Lamar KC.
    Vet Ther; 2003 Oct; 4(3):299-308. PubMed ID: 15136992
    [Abstract] [Full Text] [Related]

  • 8. Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle.
    Oliver SP, Almeida RA, Gillespie BE, Headrick SJ, Dowlen HH, Johnson DL, Lamar KC, Chester ST, Moseley WM.
    J Dairy Sci; 2004 Oct; 87(10):3322-9. PubMed ID: 15377611
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows.
    Deluyker HA, Van Oye SN, Boucher JF.
    J Dairy Sci; 2005 Feb; 88(2):604-14. PubMed ID: 15653527
    [Abstract] [Full Text] [Related]

  • 10. Intramuscular administration of ceftiofur sodium versus intramammary infusion of penicillin/novobiocin for treatment of Streptococcus agalactiae mastitis in dairy cows.
    Erskine RJ, Bartlett PC, Johnson GL, Halbert LW.
    J Am Vet Med Assoc; 1996 Jan 15; 208(2):258-60. PubMed ID: 8567385
    [Abstract] [Full Text] [Related]

  • 11. Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis.
    Morin DE, Shanks RD, McCoy GC.
    J Am Vet Med Assoc; 1998 Sep 01; 213(5):676-84. PubMed ID: 9731263
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows.
    Gillespie BE, Moorehead H, Lunn P, Dowlen HH, Johnson DL, Lamar KC, Lewis MJ, Ivey SJ, Hallberg JW, Chester ST, Oliver SP.
    Vet Ther; 2002 Sep 01; 3(4):373-80. PubMed ID: 12584673
    [Abstract] [Full Text] [Related]

  • 13. Determination of milk and mammary tissue concentrations of ceftiofur after intramammary and intramuscular therapy.
    Owens WE, Xiang ZY, Ray CH, Nickerson SC.
    J Dairy Sci; 1990 Dec 01; 73(12):3449-56. PubMed ID: 2099366
    [Abstract] [Full Text] [Related]

  • 14. Risk factors associated with short-term post-treatment outcomes of clinical mastitis.
    Pinzón-Sánchez C, Ruegg PL.
    J Dairy Sci; 2011 Jul 01; 94(7):3397-410. PubMed ID: 21700025
    [Abstract] [Full Text] [Related]

  • 15. Comparison of J5 vaccinates and controls for incidence, etiologic agent, clinical severity, and survival in the herd following naturally occurring cases of clinical mastitis.
    Wilson DJ, Grohn YT, Bennett GJ, González RN, Schukken YH, Spatz J.
    J Dairy Sci; 2007 Sep 01; 90(9):4282-8. PubMed ID: 17699047
    [Abstract] [Full Text] [Related]

  • 16. The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes.
    Lago A, Godden SM, Bey R, Ruegg PL, Leslie K.
    J Dairy Sci; 2011 Sep 01; 94(9):4441-56. PubMed ID: 21854917
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of vaccination and antimicrobial treatment to eliminate chronic intramammary Staphylococcus aureus infections in dairy cattle.
    Smith GW, Lyman RL, Anderson KL.
    J Am Vet Med Assoc; 2006 Feb 01; 228(3):422-5. PubMed ID: 16448371
    [Abstract] [Full Text] [Related]

  • 18. The selective treatment of clinical mastitis based on on-farm culture results: II. Effects on lactation performance, including clinical mastitis recurrence, somatic cell count, milk production, and cow survival.
    Lago A, Godden SM, Bey R, Ruegg PL, Leslie K.
    J Dairy Sci; 2011 Sep 01; 94(9):4457-67. PubMed ID: 21854918
    [Abstract] [Full Text] [Related]

  • 19. Short communication: Longitudinal study of quarter-level somatic cell responses after naturally occurring, nonsevere clinical mastitis diagnosed as culture negative, or caused by Escherichia coli or Klebsiella pneumoniae, and randomly assigned to a no-treatment group or to receive intramammary ceftiofur.
    Fuenzalida MJ, Ruegg PL.
    J Dairy Sci; 2019 Dec 01; 102(12):11476-11482. PubMed ID: 31629523
    [Abstract] [Full Text] [Related]

  • 20. Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental Escherichia coli-induced mastitis.
    Erskine RJ, Wilson RC, Tyler JW, McClure KA, Nelson RS, Spears HJ.
    Am J Vet Res; 1995 Apr 01; 56(4):481-5. PubMed ID: 7785826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.